MedPath

Computerized Cognitive Training for Patients With Epilepsy

Not Applicable
Withdrawn
Conditions
Epilepsy
Interventions
Behavioral: Luminosity Trial Memory Match
Behavioral: Luminosity Trial Memory Matrix
Behavioral: Luminosity Trial Famliar Faces
Behavioral: Luminosity Trial Brain Shift
Behavioral: Luminosity Trial Star Search
Behavioral: Luminosity Trial Word Bubbles
Behavioral: Luminosity Trial Color Match
Behavioral: Luminosity Trial Ebb and Flow
Behavioral: Luminosity TrialChalk Board Challenge
Behavioral: Luminosiuty Follow that Frog
Behavioral: Luminosity Train of Thought
Registration Number
NCT03644082
Lead Sponsor
NYU Langone Health
Brief Summary

This is a study on the effectiveness of computerized cognitive training for treatment of memory disorders in patients with epilepsy. Participants will be recruited from patients referred for neuropsychological assessment through the NYU Comprehensive Epilepsy Center's inpatient and outpatient services. Individuals meeting inclusion criteria will be screened for the presence of memory disturbance (defined by results of neuropsychological testing) and lack of exposure to any previous form of computerized cognitive training. All eligible subjects will be provided with an account for Lumosity with instructions to complete training modules 5 days per week for a total of 8 consecutive weeks. Outcomes will be evaluated through changes on the neuropsychological test battery.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Documented diagnosis of epilepsy based on medical records. The records will be reviewed by the PI and the approved study personnel to confirm that a diagnosis of epilepsy has been made.
  • Presence of memory disturbance, as defined by an immediate or delayed memory index score < 85 on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)
  • Availability of a home computer and internet for access to the computer training program.
Read More
Exclusion Criteria
  • Full Scale IQ < 80, as assessed by an appropriate Wechsler scale (WAIS-IV or WASI-II).
  • Epilepsy surgery within 8 weeks of the beginning of the trial.
  • History of chronic progressive neurologic or neurodegenerative illnesses (e.g., Alzheimer's disease, multiple sclerosis, primary or metastatic malignancy). Patients with headache or migraine are not excluded.
  • History of Axis I psychiatric illness with psychotic features. (e.g., schizophrenia or bipolar disorder). Patients with depression or anxiety (treated or untreated) without psychotic features are not excluded.
  • Visual or auditory impairment, which precludes participation in part, or all of the testing or computer training.
  • English as a first language will not be required, but participants must have either received some of their schooling in English or used English in their work for >10 years.
  • Previous exposure (> one week) to Lumosity or a similar computerized training program.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Epilepsy PatientsLuminosity Trial Word Bubbles-
Epilepsy PatientsLuminosity Trial Famliar Faces-
Epilepsy PatientsLuminosity Trial Brain Shift-
Epilepsy PatientsLuminosity Trial Color Match-
Epilepsy PatientsLuminosity Trial Ebb and Flow-
Epilepsy PatientsLuminosity TrialChalk Board Challenge-
Epilepsy PatientsLuminosiuty Follow that Frog-
Epilepsy PatientsLuminosity Trial Memory Match-
Epilepsy PatientsLuminosity Trial Memory Matrix-
Epilepsy PatientsLuminosity Trial Star Search-
Epilepsy PatientsLuminosity Train of Thought-
Primary Outcome Measures
NameTimeMethod
Immediate Memory Index Score12 Months

Score on the Repeatable Battery for the Assessment of Neuro-psychological Status (RBANS) will be used to measure immediate memory

Delayed Memory Index Score12 Months

Score on the Repeatable Battery for the Assessment of Neuro-psychological Status (RBANS) will be used to measure immediate memory

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

New York University School of Medicine

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath